European Archives - Page 317 of 1176 - European Medical Journal

Review of the European Alliance of Associations for Rheumatology (EULAR) 2024 Congress

THE European Alliance of Associations for Rheumatology (EULAR) 2024 Congress took place in Vienna, Austria, from June 12th–15th…

Effects of High-Intensity Resistance Training for Patients with Myositis

Reduced muscle endurance and strength are cardinal traits in patients with myositis. These traits are associated with reduced quality of…

Therapeutic Approaches for Platelet Disorders

Read on to learn more about Lowe syndrome, Bernard Soulier disease, and TAR syndrome among others in this infographic.

KMT2A-MLLT3-Induced Leukaemia Changes During Ontogenic Stages

The KMT2A-MLLT3 (also known as MLL-AF9) fusion is associated with acute lymphoid leukaemia (ALL), acute myeloid leukaemia (AML), and mixed…

Filgrastim Prophylaxis for Neutropenia in Myelodysplasia Pre-Surgery: Case Report

Myelodysplastic syndromes are a group of disorders that affect the bone marrow, subsequently affecting the growth and relative…

Chimeric Antigen Receptor T Cell Therapy in Autoimmune Disease

HOT off the press from the European Alliance of Associations for Rheumatology (EULAR) 2024 Congress was a session spotlighting the latest…

Comparison of Lung Ultrasound B-Lines and Pleural Line Alterations with Automated Quantitative CT

B-lines (BL) and pleural line alterations (PLA) are the typical lung ultrasound (LUS) findings for the detection and severity assessment…

Ageing and Haematology: The Clone Wars

IN THIS year’s European Hematology Association (EHA) Congress, held in Madrid, Spain between the 13ᵗʰ–16ᵗʰ June 2024, an insightful…

A-HIPI Prognostic Index in Turkish Patients with Hodgkin Lymphoma: Single-Center Retrospective Study

The historical International Prognostic Score (IPS-7), which was developed with patient data from the 1980s, and the more recent IPS-3…

A Debate on the Use of Gene Therapy in Patients with Haemophilia

GENE therapy is an innovative approach to treating haemophilia A and haemophilia B, with the potential to increase quality of life…